Comparative Guide
Renewable Energy
United States
Maher Haddad, Keith Hagan, Stanislav Sirot, Carlos Suarez & John Hamilton
Fielding a team of ‘excellent individuals’, the antitrust and competition practice at Baker McKenzie regularly handles complex merger control mandates, including multijurisdictional clearance matters in close coordination with the firm’s European teams. An ’excellent and very pragmatic lawyer’, Creighton Macy leads the team from Washington DC, and is particularly noted for his expertise in cartel and merger investigations. Brian Burke, also in DC, is a key contact for merger clearance across the healthcare, technology, chemicals and telecoms sectors. Former co-head Mark Hamer has left the team.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Very good bench strength, excellent individuals. Perfect fit for large mergers with multiple notifications. Especially good in pharmaceutical deals.'
- 'Nicolas Kredel is an excellent lawyer, very likeable and approachable person, always keeps his cool.'
- 'Creighton Macy is an excellent and very pragmatic lawyer, does not rush you to notifications, very deep experience/great prediction capabilities.'
Key clients
- Berkshire Hathaway
- Marel
- Lundbeck
- Methanex
- Safran
- Unilever
- Bayer AG
- Takeda
- Acuity Inc.
- Seiko Epson Corporation
- Health-Ade Holdings LLP
- Harman International Industries, Inc.
Work highlights
Acting as lead antitrust and foreign direct investment regulatory counsel for Berkshire Hathaway on its announced (but not yet closed) proposed acquisition of OxyChem for $9.7 billion.
Represented global food processor Marel in its acquisition by John Bean Technologies.
Represented H. Lundbeck A/S in its acquisition of Longboard Pharmaceuticals.
Practice head
Creighton Macy
Other key lawyers
Brian Burke; Nicolas Kredel